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Summary
In this review, Raman spectroscopy is described as a new and
potentially powerful diagnostic tool in comparison to routine
biochemical tests. Advanced instrumentation and new
Raman spectroscopy techniques enable rapid and simultane-
ous identification and/or determination of se veral biochemi-
cal parameters, such as glucose, acetone, creatinine, urea,
lipid profile, uric acid, total protein, etc, with a very low limit
of detection. Raman spectroscopy could also be applied in
molecule and cell characterization, as well as diagnostics of
atherosclerosis in its early stage. Raman spectroscopy is non-
destructive and could be applied to all kinds of samples,
which simplifies the diagnostics of numerous disea ses and
pathologic states. Special attention is paid to literature data
illustrating the application of Raman spectroscopy for trans-
dermal glucose monitoring and cancer diagnostics.
Keywords: biochemical parameters, cancer diagnosis,
glu cose monitoring, Raman spectroscopy
Kratak sadr`aj
U ovom prikazu opisana je primena Ramanske spektrosko -
pije kao nove metode velikih mogu}nosti u dijagnostici, u
pore|enju sa rutinskim biohe mijskim testovima. Me toda je
razvijena i usavr{ena za identifikaciju i/ili odre |ivanje velikog
broja biohemijskih parametara, kao {to su glu koza, aceton,
kreatinin, urea, lipidni profil, mokra}na kiselina, ukupni pro-
teini i drugi, uz veoma nizak limit detekcije. Ramanska spek-
troskopija tako|e se mo`e primenjivati u molekulskoj i }elij -
skoj karakterizaciji, kao i za dijagnostiku ranog stadijuma
ateroskleroze. Ramanska spektroskopija je nedestruktivna i
mo`e se primenjivati na sve vrste uzoraka, {to pojednostavlju-
je dijagnostiku brojnih bo lesti i patolo{kih stanja. Posebna
pa`nja u radu je posve }ena podacima iz literature koji ilustru-
ju primenu Ramanske spektroskopije u transdermalnom mo -
nitoringu glukoze i dijagno stici kancera.
Klju~ne re~i: biohemijski parametri, dijagnostika kan -
cera, monitoring glukoze, Ramanska spektroskopija
that Raman spectroscopy is able to analyze samples
without prior preparation in most cases makes this
method suitable for biochemical diagnostics, and that
is confirmed in this review by numerous literature
data. 
Based on the Raman effect (see Figure 1) new
spectroscopic instrumentation was developed, and
very soon became applicable, thanks to lasers devel-
oped as monochromatic light sources as well as more
sophisticated detectors. The method is based on the
intensity measurement of inelastic incoherent light
after the sample is illuminated with a monochromatic
light source. Obtained spectra enable qualitative and
quantitative analyses. 
The Raman technique was applied for biological
molecules characterization very soon after the Raman
phenomenon was discovered in 1928 (1). But for
Introduction
An ideal method for the identification and deter-
mination of important biochemical parameters should
be fast, reliable, specific, accurate and as low-cost as
possible. The advantage of some spectroscopic meth-
ods is in avoiding sample preparation and reagents
for each parameter separately, in comparison to most
routine tests based on chemical reactions. The fact
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decades, due to problems with spectra quality and/or
their understanding, there was no practical applica-
tion of Raman spectroscopy in biochemical diagnos-
tics. A connection of physical and analytical chemistry
with biochemical diagnosis is necessary, especially
with a view to establishing practical applications of
more sophisticated, reliable and low-cost instrumen-
tal techniques. 
Raman spectroscopy has been used before for
qualitative analysis. The advantages of newly
designed instruments equipped with holographic
optical elements, charge-coupled device cameras,
long wavelength solid state lasers and chemometric
methods, facilitate the measurement of concentra-
tions with Raman spectrometers with a low limit of
detection (LOD) in comparison to the other spectro-
scopic techniques (2). For more than a decade,
Raman spectroscopy has been considered as a pow-
erful diagnostic tool in biochemistry (3–7). 
Nowadays, there are several advanced Raman
spectroscopy techniques: 
a) Fourier Transform Raman Spectroscopy, since
the early 1980s; 
b) Near-Infrared Raman Spectroscopy provides a
good quality spectrum recorded from in vivo human
skin in less than 1 s, enabling Raman data collection
in the clinical surroundings with good S/N values at
the same time; 
c) Resonant Raman Spectroscopy allows deter-
mination of analytes with 102–106 times higher sen -
si ti vity than conventional Raman techniques, while
the obtained spectra are simpler shaped than usual; 
d) Micro-Raman spectroscopy can be applied for
more specified investigation of biosamples, and leads
to a completely nondestructive technique when com-
bining laser tweezers with confocal micro-Raman
spectroscopy; 
e) Resonant Micro-Raman Spectroscopy achiev -
es lowering of the sample mass required; 
f) Surface-Enhanced Raman Spectroscopy (SERS)
is a technique based on the phenomenon that a com-
pound adsorbed to a metal surface has 103–106
times stronger Raman scaterring, so the obtained
spectra may give much more information. 
Literature data describe the potential application
of Raman spectroscopy in the diagnosis of atheroscle-
rosis, analysis of biological fluids (with special atten-
tion on non-invasive glucose monitoring), microbial
identification, diagnosis of skin diseases, and diagno-
sis of cancer. We review some of these here.
Biochemical Parameters
Raman spectroscopy allows very fast determina-
tions in different biological samples, such as urine or
whole blood. A study by Dou et al. (8) reports the pos-
sibility for quantification of components of human
urine based on anti-Stokes Raman spectra, to determi -
ne the concentrations of glucose, acetone, and urea.
Raman spectroscopy is obviously a very power-
ful tool in biochemistry, especially if measured diag-
nostic parameters can be connected to prognosis of
future state, particularly significant for arthrosclerotic
conditions. For example, the precise definition and
understanding of the lipid profile in high-risk groups
of patients is very important. Raman spectroscopy
studies were usually undertaken to clarify the struc-
ture of lipoprotein, and they were performed on bulk
solutions of lipoproteins (9), giving as a result aver-
aged information about the size and density of
lipoproteins (10). 
The most advanced applications of Raman spec -
 troscopy nowadays are directed to atherosclerotic vas-
cular disease. Current atherosclerosis research is
focused on unstable plaques; a thin fibrous top over
collected necrotic lipid material that mainly consists
of cho lesterol (11). Recent studies have shown that
che mical composition and morphology determine
athe ro sclerotic plaque instability, and predict disease
progression and the risk of complications such as
throm bosis and acute plaque hemorrhage. The pro-
gression and regression of atherosclerotic plaques
appear to be related to the amount and type of lipids
that accumulate in blood vessels (12). 
Raman microspectroscopy has been used for in
situ characterization of cholesterol crystals in artery
endothelial cells (13). The study of Chan et al. (14)
goes further showing that the biomolecular Raman
spectroscopic fingerprint of individual very low densi-
ty lipoproteins (VLDL) is unique, highly reproducible
and can be used to monitor biochemical changes of
the particles due to lipoprotein metabolism. Addi -
tionally, the free unsaturated and saturated fatty acids
can pack into different phases, leading to the forma-
tion of a highly ordered saturated core, which can be
detected spectroscopically. Any information in this





















area can help in the creation of measurements for the
monitoring of at-risk cardiovascular patients. 
Raman spectroscopy is even able to give the an -
swer to how advanced is the calcification process of ath-
erosclerotic plaques in human coronary arteries (15, 16).
Glucose level data, as well as some other bio-
chemical parameters, can be followed by the pro-
posed technique, such as creatinine, urea and cho -
lesterol, in addition to several other tissue diagnosis
applications. For that purpose the application of a
non-imaging optical element – compound hyperbolic
concentrator (CHC) is proposed, which enables ac -
com modation of a wide angular range of scattered
photons from the biological tissue by conversion into
a limited range of angles (17).
Near-infrared Raman spectroscopy can be a
new technique for physical evaluations, allowing the
measurement of lactic acid concentrations, in blood
or muscles, during physical activity in a transcuta-
neous noninvasive way. Raman spectroscopy has
been used to follow the content of lactic acid from an
athlete without interrupting his exercise for sample
collection (18). Experiments were undertaken to veri-
fy the presence of lactic acid in the Raman spectra of
solutions of lactic acid in human serum and in blood
from a Wistar rat. After these two experiments, anoth-
er was developed in vivo in a Wistar rat, by injecting
intraperitoneally 1 mL of a 0.12 mol/L lactic acid
aqueous solution. An optical fiber catheter touching
the skin of the rat groin over the ileac vein collected
the Raman signal. 
Glucose Monitoring
The monitoring of glucose concentrations in
patients who suffer from diabetes has been estab-
lished as imperative, as a result of some early studies
showing that tight control of blood glucose concen-
trations, by frequent testing of the glucose level and
adequate corrections of insulin doses, decreases the
possible long-term complications diabetes could
cause (19). 
A study performed by Rohleder et al. (20) con-
cerned Raman spectroscopy as a reagent-free tool for
predicting the concentrations of several biochemical
parameters in serum and/or serum ultrafiltrate. For
samples from 247 blood donors, the concentrations
of glucose, triglycerides, urea, total protein, choles-
terol, high density lipoprotein, low density lipoprotein
and uric acid were determined with accuracy within
the clinically interesting range. Relative errors of pre-
diction, based solely on the Raman spectra, were
around 12%. This study also showed that ultrafiltra-
tion can efficiently reduce fluorescent light back-
ground to improve prediction accuracy. Raman spec-
troscopy was presented as a powerful diagnostic
technique when costs and time of analysis take prece-
dence over high accuracy.
Classic invasive blood sample collection is pain -
ful, discomforting, could be connected with infec-
tions, requires sharp objects, and may result in a
patient’s avoiding of frequent glucose level checking.
Finding some noninvasive procedure for measuring
glucose would be a great benefit for the millions of
people affected by diabetes. 
Several techniques seemed to be useful for the
abovementioned purpose, such as infrared spectro -
scopy, fluorescence spectroscopy, electrochemical
measurements, NMR spectroscopy and some others,
but for the time being all of them are not conve nient
for regular application. 
Some implantable sensors for glucose may be
efficient, but they are certanly invasive (21). The level
of glucose in blood corresponds to the glucose level
in interstitial fluid, and makes a base for the transcu-
taneos determination of glucose by Ra man spec-
troscopy. Calculations confirmed that about 30% of
Raman spectra intensity collected in vitro could be
collected in interstitial fluid in vivo (22). 
In order to obtain good quality – »useful« Ra man
spectra, it is necessary to use high excitation power
and long time of signal collection. The imperative is to
stay within a safe level of irradiance and be sure that
no skin irritation or damage could occur. Accor ding to
the American National Standards Institute, skin expo-
sure to an 830 nm laser beam for 10 s at 0.36 W/cm2
is marked as level of comfort (23). 
A Raman signal obtained by measuring biologi-
cal samples, such as skin, is very weak and over-
lapped by strong fluorescence signals. Fluorescence
background is partly reduced by using an excitation
laser at 830 nm. Further, fluorescence background
varies from sample to sample, and with the exposure
time, as well. This is the reason why it is necessary to
remove the influence of broad fluorescence back-
ground by a high-pass filter. As an example proce-
dure, after least square fitting a fifth order polyno mial
spectral curve, and subtraction of raw skin spectrum,
only a sharp Raman spectrum remains (24). 
Raman bands are specific to glucose molecular
structure. The vibrations monitored in Raman spectra
are fundamental and thus are sharper. Further, water
has a low Raman cross-section as opposed to its high
IR absorption. It is possible to detect glucose by mon-
itoring the 2900 cm–1 COH stretch band or the COO
and COC stretch Raman bands at 900–1200 cm–1,
which represents a fingerprint for glucose (25). 
At the present time, a non-imaging optics based
portable Raman spectroscopy instrument has been
constructed with the aim of measuring transdermal
blood glucose (17). The proposed non-imaging opti-
cal element is a so-called compound hyperbolic con-
centrator, and at the same time is able to follow some
other biochemical parameters (creatinine, urea and
cholesterol).
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Although the proposed method seems promis-
ing, it is still the subject of testing performed by tissue
phantom, animal model, and human subject studies
(26). 
Raman Spectroscopy in Cancer
Diagnosis 
Innovations in the Raman spectroscopic instru-
mentation have improved the sensitivity of the mea -
surement and allowed the obtaining of useful spectra
from biological tissue and cells. Several studies have
confirmed the possible use of Raman spectroscopy
for the identification and classification of malignant
changes (27–29). 
All cancer stages are followed by fundamental
changes in cellular morphology and/or tissue bio-
chemistry. During the process of carcinogenesis,
some changes in the distribution of DNA, lipids and
proteins in the cells occur. These could be early mark-
ers in the detection of high-risk patients before mor-
phological changes appear. A study by Shetty et al.
(30) is an important contribution to establishing these
biochemical changes. Further understanding of the
carcinogenesis process would help to improve the
diagnostic techniques, thus improving survival.
Beside diagnostics, Raman spectroscopy can be
applied in cancer biology in the detection of specific
changes in the structure of DNA or proteins, and thus
may be used to follow the chemotherapeutic action of
several drugs (31).
Studies in which Raman spectroscopy was used
to help in differential diagnosis of malignancy were
applied in several kinds of tumors. Cervical cancer is
the second most common cancer in women world-
wide, and the mortality associated with cervical can-
cer can be reduced if this disease is detected at the
early stages. The results of Lyng et al. (32) show that
Raman spectroscopy displays high sensitivity to bio-
chemical changes in tissue during disease progres-
sion resulting in excellent accuracy in the discrimi -
nation between normal cervical tissue, invasive
carci noma and cervical intraepithelial neoplasia. 
The diagnostics of breast cancer was also the
subject of a Raman spectroscopy investigation. In the
study of Bitar et al. (33), the assignment of the appro-
priate Raman bands enabled them to connect seve ral
kinds of breast tissues, normal and pathological, to
their corresponding biochemical moieties alterations
and to distinguish among 7 groups: normal breast,
fibrocystic condition, duct carcinoma in situ, duct car-
cinoma in situ with necrosis, infiltrating duct carcino-
ma not otherwise specified, colloid infiltrating duct
carcinoma, and invasive lobular carcinomas. 
Raman spectroscopy continues to push its fron-
tier, enabling individual neoplastic cell identification,
such as shown in the works of Chan et al. (34, 35).
Owing to improved and advanced Raman techniques,
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Figure 2 SERS Spectra (A1 and B1), PC plots (A2 and B2), and loading spectra (A3 and B3) of tumor (red) and nontumor (blue)
breast (A) and prostate (B) cell lines. Reprinted with the permission from J Phys Chem Lett 2010; 1: 1595–1598. Copyright
(2012) American Chemical Society.
they confirmed that it is possible to distinguish normal
and neoplastic cells as well. 
Cell surface is a very important target in investi-
gations focused on carcinogenesis processes. The
work of Bo et al. (36) gave results of exploring the cell
surface in cases of breast and prostate cancers, and
healthy cells as well, by SERS with Ag nanoparticles as
substrate. Obtained spectra differ, especially in the
region of 600–900 cm–1. Detection of specific differ-
ences in the recorded SERS spectra gave the scien-
tists the clue to introduce biomarkers for tumor cells
surface. We found the following example (36) would
be illustrative for the wide audience of the journal. 
SERS measurements were performed on an
upright microscope equipped with a 300 mm focal
length imaging spectrometer and a back-illuminated
CCD camera optimized for the near-infrared. A 600
lines/mm grating with a blazing wavelength of 750
nm was used. The laser light was injected into the
objective and focused onto the sample plane. The
laser power at the sample was 21.5 mW. The active
area for recording SERS spectra was limited by a slit
in the entrance port of the spectrometer to 2 mm x 78
μm. Typically 4–5 cells filled this region. Ten individ-
ual acquisitions with a 2 s integration time were accu-
mulated for each spectrum. Each spectrum comes as
the average of 36 scans in three independent experi-
ments.
Figure 2 shows examples of the spectra of tumor
and nontumor breast and prostate cells. The dashed
lines in Figure 2B1 show the spectra of supernatant
prostate cells recorded under the same conditions as
the tumor cells SERS spectra background. The differ-
ences between the spectra of tumor and nontumor
cells are evident. PC plots (so-called scores) were
obtained by software simplification of the spectral
data (Figures 2A2 and 2B2). The PC values for the
individual measurements in a data set provide a
quantitative measure of the differences between com-
plex spectra. The loading spectra of these PCs are
shown in Figures 2A3 and 2B3. In both cases, the
722 cm–1 band has the highest absolute contribution
to the PC. This finding indicates that cancer-specific
changes in the cell surface chemi stries, which are
independent of the cell source (breast or prostate),
cause the intensity differences in the 722 cm–1 band.
The 722 cm–1 band arises from molecular species
located at the cell surface, so this band was assigned
to the C-N bond of quaternary ammonium groups in
phosphatidylcholines and sphingomyelins, which are
the main components of the membrane lipid bilayer.
Raman Microspectroscopy of Single
Cells
The analysis of biological samples and tissues is
very complicated, among other things, due to thou-
sands of molecule signals overlapping and the certain
possibility that signals with low intensities could be
masked if a visible excitation laser source is used. The
introduction of an Nd-YAG laser working at 1064 nm
grants the application of Raman spectroscopy as a
diagnostic tool in different pathologic states (37). The
authors gave the Raman microspectroscopy results of
individual cells astrocytoma, and some of the repre-
sentative Raman spectra in the wavenumber range
600–1800 cm–1. The protein bands characteristic of
the a helix or collagen helix, DNA bands, and choles-
terol bands indicated the differences between healthy
and tumor cells.
This demonstrated the applicability of Raman
spectroscopy for real-time and in vivo diagnosis dur-
ing neurosurgery. Raman spectroscopic methods
might contribute to tumor diagnosis and to defining
exact margins intraoperatively, leaving healthy and
functional brain tissue intact.
Raman microspectroscopy combines molecular
specificity with diffraction-limited resolution in the
submicrometer range and can be applied under in
vivo conditions without fixatives, markers, or stains.
After the same steps as explained in the previous
example, authors gave the obtained spectra of a dried
human osteogenic sarcoma cell (37). The data set
was obtained by exciting with a 785 nm diode laser,
collecting spectra with 1 min exposure time, and sub-
sequently moving the sample in a raster pattern to
map a defined area. Raman bands in raw spectra
were assigned to proteins, lipids, and nucleic acids.
On the basis of the spectral information the main cel-
lular constituents were highlighted in false color plots.
Because image contrast reflects the molecular prop-
erties of the specimen, this approach is often called
»molecular staining«. 
Details of the instrumentation, the analysis, and
data from cells in medium have been published else-
where (38). Similar mapping experiments on fixed
single cells have also been described by another
group (39). The methodology can even be applied to
studies of living cells. It was recently shown for murine
lung epithelial cells that their viability was apparently
not affected after prolonged irradiation at 785 nm
with laser power up to 115 mW, whereas significant
morphology changes occurred in cells irradiated with
488 and 514 nm lasers, even with laser power as low
as 5 mW (40). Other studies of single cells by Raman
spectroscopy involved signal-enhancement methods,
for example studies of hemoglobin in single living
eryth rocytes (41). This special application took ad -
van tage of the presence of hemoglobin at high con -
centrations and the fact that the Raman signals of
hemoglobin are enhanced by resonance effects. 
Results of a study performed by Wang at al. (42)
found protein mucin (MUC4) in considerably high lev-
els in pancreatic adenocarcinoma patients, while vol-
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unteers with normal pancreas and chronic pancreatitis
had undetectable levels of MUC4. How ever, the meas-
urement of MUC4 in sera using conventional test plat-
forms, ELISA and RIA, has been unsuccessful. This
has prevented the assessment of the utility of this pro-
tein as a possible pancreatic cancer marker in sera. 
The Raman spectra were collected with a fiber-
optic-based Raman system, a portable, field-deploy-
able instrument. The light source was a 30 mW,
632.8 nm He-Ne laser. The spectrograph consisted
of an imaging spectrometer (6–8 cm–1 resolution)
and a CCD at 0 °C. The incident laser light was
focused to a 25 mm spot on the substrate. The ana-
lyte concentration was quantified using the peak
intensity of the symmetric nitro stretch (ns(NO2)) of
NTP at 1336 cm–1. Results of SERS-based assays for
MUC4 in PBS buffer are shown in Figure 3 (42). 
The team created a simple diagnostic test for
MUC4 through the development of a SERS-based
immunoassay. The results indicate that a SERS-based
immunoassay can monitor MUC4 levels in patient
sera, representing a much needed first step toward
assessing the potential of this protein to serve as a se -
rum marker for the early stage diagnosis of pancre atic
cancer, and demonstrate that the SERS assay outper-
forms conventional assays with respect to limits of
detection, readout time, and required sample volume. 
Conclusion
Raman spectroscopy facilitates the determina-
tion of the most frequent biochemical parameters,
such as glucose, acetone, creatinine, urea, lipid pro-
file, uric acid, and total protein, but also of very speci -
fic ones. Development of modern Raman techniques
ena bles the following of the degree and type of athe -
ro sclerotic changes in coronary arteries. A broad body
of literature deals with the application of Raman spec-
troscopy in transdermal glucose monitoring with the
aim of helping patients with one of the most spread
diseases worldwide – diabetes. Valuable information
can be obtained for the diagnostics of cancer in its
very early stage, and some other diseases could be
monitored  as well based on the fact that the spectra
of healthy/normal cells/tissues and pathologic ones
differ according to their chemical characteristics. One
of the future goals in this field is developing kits based
on data obtained by the Raman spectra. 
Thanks to numerous research groups all over
the world focusing on further development of Raman
spectroscopy, we hope that very soon this method will
transform from a »promising analytical tool« to a rou-
tine and powerful biochemical technique. 
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Figure 3 SERS-based assay for MUC4 in PBS buffer. (A)
SERS spectra acquired at various CD18/HPAF cell lysate con-
centrations. (B) Dose-response curve for MUC4 prepared by
serially diluting CD18/HPAF cell lysates. (C) Low concentra-
tion range on a linear scale. Data points are the average of
three separate assays, and the error bars are their standard
deviations. Reprinted with the permition from Anal Chem















Total Protein Concentration (μg/mL)
Total Protein Concentration (μg/mL)
0.0 0.2 0.4 0.6 0.8 1.0

















































1. Edsall JT. Raman spectra of amino acids and related
compounds I. The ionization of the carboxyl group. J
Chem Phys 1936; 4: 1–6.
2. Yang SY, Hasty CE, Watson PA, Wicksted JP, Smith RD,
March WF. Analysis of metabolites in aqueous solutions
by using laser Raman spectroscopy. Appl Opt 1993; 32:
925–9.
3. Andrew JB, Koo TW, Itzkan I. Multicomponent blood
analysis by near-infrared Raman spectroscopy. Appl Opt
1999; 38(13): 2916–26. 
4. Enejder AMK, Koo TW, Oh J, Hunter M, [a{i} S,
Horowitz GL, Feld MS. Blood analysis by Raman spec-
troscopy. Opt Lett 2002; 27(22): 2004–6. 
5. Sideroudi TI, Pharmakakis NM, Papatheodorou GN,
Voyiatzis GA. Non-invasive detection of antibiotics and
physiological substances in the aqueous humor by
Raman spectroscopy. Lasers Surg Med 2006; 38(7):
695–703.
6. Barman I, Singh GP, Dasari RR, Feld MS. Turbidity-cor-
rected Raman spectroscopy for blood analyte detection.
Anal Chem 2009; 81: 4233–40.
7. Huk JS, Chung AJ, Erickson D. Surface enhanced Raman
spectroscopy and its application to molecular and cellular
analysis. Microfluid Nanofluid 2009; 6: 285–97.
8. Dou X, Yamaguchi Y, Yamamoto H, Doi S, Ozaki Y.
Quan titative analysis of metabolites in urine by anti-
Sto kes-Raman spectroscopy. Biospec 1997; 3: 113–20.
9. Verma SP, Philippot JR, Bonnet B, Saintemarie J,
Moschetto Y, Wallach DFH. Resonance Raman spectra of
beta-carotene in native and modified low-density lipopro-
tein. Biochem Biophys Res Comm 1984; 122: 867–75.
10. Vlasova IM, Dolmatova EV, Koshelev VB, Saletsky AM.
Investigation of ischemia damaging action on blood
serum structure by laser spectroscopy methods. Laser
Phys Lett 2004; 1: 417–20.
11. Römer TJ, Brennan JF, Fitzmaurice M, Feldstein ML,
Deinum G, Myles JL, et al. Histopathology of human
coronary atherosclerosis by quantifying its chemical com-
position with Raman spectroscopy. Circulation 1998; 97:
878–85.
12. Bushman HP, Motz JT, Deinum G, Römer TJ, Fitzmaurice
M, Kramer JR, et al. Diagnosis of human coronary athero -
sclerosis by morphology-based Raman spectroscopy.
Cardiovasc Pathol 2001; 10: 59–68.
13. Hawi SR, Nithipatikom K, Wohlfeil ER, Adar F, Campbell
WB. Raman microspectroscopy of intracellular choles-
terol crystals in cultured bovine coronary artery endothe-
lial cells. J Lipid Res 1997; 38: 1591–7.
14. Chan JW, Motton D, Rutledge JC, Keim NL, Huser T.
Raman spectroscopic analysis of biochemical changes in
individual triglyceride-rich lipoproteins in the pre- and
postprandial state. Anal Chem 2005; 77: 5870–6.
15. Rocha R, Villaverde AB, Pasqualucci CA, Silveira L, Brug -
nera A, Costa MS, et al. Identification of calcifications in
cardiac valves by near infrared Raman spectroscopy.
Photomed Laser Surg 2007; 25: 287–90.
16. Rocha R, Silveira L, Villaverde AB, Pasqualucci CA, Costa
MS, Brugnera A, et al. Use of near infrared Raman spec-
troscopy for identification of atherosclerotic plaques in
the carotid artery. Photomed Laser Surg 2007; 6:
482–6.
17. Kong CR, Barman I, Dingari NC, Kang JW, Galindo L,
Dasari RR, Feld MS. A novel non-imaging optics based
Raman spectroscopy device for transdermal blood ana-
lyte measurement. AIP Adv 2011; 1(3): 32175. 
18. Pilotto S, Pacheco MTT, Silveira LJr, Balbin Villaverde A,
Zangaro RA. Analysis of near-infrared Raman spectro -
scopy as a new technique for a transcutaneous non-inva-
sive diagnosis of blood components. Las Med Sci 2001;
16: 2–9. 
19. The Diabetes Control and Complications Trial Research
Group. The effect of intensive treatment of diabetes on
the development and progression of long-term complica-
tions in insulin-dependent diabetes mellitus. N Engl J
Med 1993; 329: 977–86.
20. Rohleder D, Kieferb W, Petrich W. Quantitative analysis of
serum and serum ultrafiltrate by means of Raman spec-
troscopy. Analyst 2004; 129: 906–11.
21. Wilson GS, Zhang Y, Reach G, Moatti-Sirat D, Poitout V,
Thevenot DR, et al. Progress toward the development of
an implantable sensor for glucose. Clin Chem 1992; 38:
1613–17. 
22. Jensen BM, Bjerring P, Christiansen JS, Orskov H. Glu -
cose content in human skin: Relationship with blood glu-
cose levels. Scand J Clin Lab Invest 1995; 55: 427–32. 
23. ANSI.Z 136-1 Safe Use of Lasers, American National
Standards Institute, 2000. 
24. Enejder AM, Scecina TG, Oh J, Hunter M, Shih WC,
Sasic S, Horowitz GL, Feld MS. Raman spectroscopy for
noninvasive glucose measurements. J Biomed Opt 2005;
10(3): 031114.
25. Berger AJ, Wang Y, Feld MS. Rapid, noninvasive concen-
tration measurements of aqueous biological analytes by
near-infrared Raman spectroscopy. Appl Opt 1996; 35:
209–12.
26. Dingari NC, Barman I, Singh GP, Kang JW, Dasari RR,
Feld MS. Investigation of the specificity of Raman spec-
troscopy in non-invasive blood glucose measurements.
Anal Bioanal Chem 2011; 400: 2871–80.
27. Kendall C, Stone N, Shepherd N, Geoboes K, Warren B,
Bennett R, Barr H. Raman spectroscopy, a potential tool
for the objective identification and classification of neo-
plasia in Barrett’s oesophagus. J Pathol 2003; 200:
602–9. 
28. Stone N, Kendall C, Smith J, Crow P, Barr H. Raman
spectroscopy for identification of epithelial cancers. Fara -
day Discuss 2004; 126: 141–57; discussion 169–83.
29. Haka AS, Shafer-Peltier KE, Fitzmaurice M, Crowe J,
Dasari RR, Feld MS. Identifying microcalcifications in
benign and malignant breast lesions by probing differ-
ences in their chemical composition using Raman spec-
troscopy. Cancer Res 2002; 62(18): 5375–80. 
102 Uskokovi}-Markovi} et al.: Raman spectroscopy in biochemical diagnostic
30. Shetty G, Kendall C, Shepherd N, Stone N, Barr H. Ra -
man spectroscopy: elucidation of biochemical changes in
carcinogenesis of oesophagus. Brit J Canc 2006; 94:
1460–4. 
31. Gao X, Butler IS, Kremer R. A near-infrared Fourier trans-
form Raman spectroscopy of epidermal keratinocytes:
changes in the protein-DNA structure following malig-
nant transformation. Spectrochim Acta A 2005; 61:
27–35.
32. Lyng F, O’Faolain E, Conroy J, Meade A, Knief P, Duffy B,
et al. Vibrational spectroscopy for pathology from bio-
chemical analysis to diagnostic tool. Exp Mol Path 2007;
82: 121–9.
33. Bitar RA, Martinho HS, Tierra-Criollo CJ, Zambelli
Ramalho LN, Netto MM, Martin AA. Biochemical analy-
sis of human breast tissues using Fourier-transform
Raman spectroscopy. J Biomed Opt 2006; 11: 054001. 
34. Chan JW, Taylor DS, Lane S, Zwerdling T, Tuscano J, Hu -
ser T. Non-destructive identification of individual leuke -
mia cells by laser tweezers Raman spectroscopy. Anal
Chem 2008; 80: 2180–7.
35. Chan JW, Taylor DS, Zwerdling T, Lane S, Ihara K, Huser
T. Micro-Raman spectroscopy detects individual neoplas-
tic and normal hematopoietic cells. Biophys J 2006;
90(2): 648–56.
36. Bo Y, Bjorn MR. Identification of tumor cells through
spectroscopic profiling of the cellular surface chemistry. J
Phys Chem Lett 2010; 1: 1595–8.
37. Krafft C. Bioanalytical applications of Raman spec-
troscopy. Anal Bioanal Chem 2004; 378: 60–2.
38. Krafft C, Knetschke T, Siegner A, Funk RHW, Salzer R.
Map ping of single cells by near infrared Raman micro -
spectroscopy. Vib Spectrosc 2003; 32: 75–83.
39. Uzunbajakava N, Lenferink A, Kraan Y, Willekens B,
Vrensen G, Greve J, et al. Nonresonant Raman imaging
of protein distribution in single human cells. Biopolymers
2003; 72: 1–9. 
40. Notingher I, Verrier S, Romanska H, Bishop AE, Polak
JM, Hench LL. In situ characterization of living cells by
Raman spectroscopy. Spectroscopy – Int J 2002; 16(2):
43–51.
41. Wood BR, McNaughton D. Micro-Raman Characte ri za -
tion of High- and Low-SpinHeme Moieties within Single
Living Erythrocytes. Biopolymers 2002; 67: 259–62. 
42. Wang G, Lipert R, Jain M, Kaur S, Chakraboty S, Torres
MP, et al. Detection of the potential pancreatic cancer
marker MUC4 in serum using surface-enhanced Raman
scattering. Anal Chem 2011; 83: 2554–61.
J Med Biochem 2013; 32 (2) 103
Received: May 5, 2012 
Accepted: September 21, 2012
